TITLE

A career of making good things happen for patients

AUTHOR(S)
Williams, Lewis E.
PUB. DATE
October 2010
SOURCE
American Journal of Health-System Pharmacy;10/1/2010, Vol. 67 Issue 19/20, p1659
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
In this article, the author discusses the role of pharmacists in patient care. He asserts that his biggest satisfaction comes from the improved patient outcomes, patient's acceptance of clinical services, and resolving challenges. He notes that the development of a weight-based nomogram for the use of heparin decreased the mortality risk in obese patients suffering from pulmonary embolism (PE) or deep vein thrombosis.
ACCESSION #
53945880

 

Related Articles

  • Fondaparinux is as effective and safe as unfractionated heparin for pulmonary embolism.  // BMJ: British Medical Journal (International Edition);3/6/2004, Vol. 328 Issue 7439, p532 

    Raises the question of whether or not fondaparinux is as safe and effective as unfractionated heparin for treating pulmonary embolism. How alternatives to unfractionated heparin are widely used for treating deep vein thrombosis; Level of evidence.

  • LOW-MOLECULAR-WEIGHT HEPARIN FOR PE. Grimm, Kenneth J.; French, Linda // Journal of Family Practice;Dec1997, Vol. 45 Issue 6, p467 

    This article presents a study that examined the effectiveness of tinzaparin therapy in the treatment of acute pulmonary embolism. Low-molecular-weight heparins have been well studied in the treatment of deep venous thrombosis (DVT), with a least 25 different prospective trials and three...

  • Fondaparinux is as effective and safe as unfractionated heparin for pulmonary embolism.  // BMJ: British Medical Journal (International Edition);3/6/2004, Vol. 328 Issue 7439, p532 

    Raises the question of whether or not fondaparinux is as safe and effective as unfractionated heparin for treating pulmonary embolism. How alternatives to unfractionated heparin are widely used for treating deep vein thrombosis; Level of evidence.

  • Formulary Management of Low Molecular Weight Heparins. Wade, W.E.; Martin, B.C.; Kotzan, J.A.; Spruill, W.J.; Chisoholm, M.A.; Perri, M. // PharmacoEconomics;2000, Vol. 17 Issue 1, p1 

    Low molecular weight heparins (LMWHs) are increasingly being utilised as anticoagulants in healthcare settings. These agents offer several advantages over standard unfractionated heparin. Indications for LMWHs include deep vein thrombosis and pulmonary embolism prophylaxis, deep vein thrombosis...

  • Unfractionated Heparin Three Times a Day versus Enoxaparin in the Prevention of Deep Vein Thrombosis in Trauma Patients. ARNOLD, JOSHUA D.; DART, BENJAMIN W.; BARKER, DONALD E.; MAXWELL, ROBERT A.; BURKHOLDER, HANS C.; MEJIA, VICENTE A.; SMITH, PHILIP W.; LONGLEY, JOY M. // American Surgeon;Jun2010, Vol. 76 Issue 6, p563 

    Venous thromboembolic disease is a significant source of morbidity and mortality in hospitalized trauma patients. Multiple drugs and dosing regimens have been suggested for pharmacoprophylaxis. In this study, we compared efficacy, complications, and cost of unfractionated heparin administered...

  • DEEP VEIN THROMBOSIS AFTER RENAL TRANSPLANTATION. Joffe, Stephen N. // Vascular Surgery;May/Jun1976, Vol. 10 Issue 3, p134 

    Postoperative deep vein thrombosis has been demonstrated in four out of seven (57%) unselected patients undergoing homograft cadaveric renal transplantation, with pulmonary embolism in one. The diagnosis being made by using the combined 125I-fibrinogen and Doppler ultrasound techniques. The late...

  • Thromboprophylaxis does not protect severely injured patients against pulmonary embolism. Velmahos, George C.; Toutouzas, Konstantinos G.; Brown, Carlos; Vassiliu, Pantelis; Gkiokas, George; Rhee, Peter // American Surgeon;Oct2004, Vol. 70 Issue 10, p893 

    The existing evidence on the effectiveness of thromboprophylaxis after trauma is conflicting. Although prophylaxis with heparin and/or sequential compression devices is practiced widely, many studies failed to document a clear benefit. A recent meta-analysis suggests that prophylaxis does not...

  • Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve. Abdel-Razeq, Hikmat // Annals of Thoracic Medicine;Oct-Dec2010, Vol. 5 Issue 4, p195 

    Venous thromboembolism (VTE), comprising life-threatening pulmonary embolism (PE) and its precursor deep-vein thrombosis (DVT), is commonly encountered problem. Although most patients survive DVT, they often develop serious and costly long-term complications. Both unfractionated heparin and low...

  • Thromboembolic risk after knee endoprosthesis. Prejbeanu, R.; Vermesan, H.; Dragulescu, S. I.; Vermesan, D.; Motoc, A.; Sabatini, R.; Santacroce, L.; Cagiano, R. // European Review for Medical & Pharmacological Sciences;Sep2007, Vol. 11 Issue 5, p297 

    Thromboembolic complications are the most frequent associated pathologies after knee replacement. The secondary deep vein thrombosis in the knee arthroplasty is often low symptomatic or asymptomatic and, sometime, it could lead to fatal pulmonary embolism. This is the main purpose recommending...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics